Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
CBD Life Sciences Inc.
- Market Cap
- Unavailable
- Price
- $0.0002
- % Change (Daily % change from the live per-ticker quote feed.)
- 0.00%
- Volume
- 276.6K
About
CBD Life Sciences Inc. specializes in formulating and distributing a broad array of organic items infused with cannabidiol. Their extensive range of natural CBD offerings includes hemp tinctures, topical massage oils, targeted recovery and pain relief balms, dietary aids to support anxiety and restful sleep, various consumable treats, and a dedicated collection of products for animal companions. The company's principal operations are conducted from Scottsdale, Arizona.
Quick stats
Quick-stats data pending — refreshes nightly.
Key info
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001776073
Websitehttps://www.thecbdvault.com
AI Summary
AI-generated1/5
standardbullishproduct launch
CBD Life Sciences Inc. (CBDL) Announces Launch of CBD Flavored Vapes
CBD Life Sciences Inc. (OTC:CBDL) announced the launch of its new CBD Flavored Vapes, which are nicotine-free and available in four flavors: Menthol, Berry, Tropical, and Mint.
The CBD Vapes market is projected to grow from US$ 5.8 billion in 2026 to US$ 20.9 billion by 2033, with a CAGR of 20.5%.
CEO Lisa Nelson stated that CBD vapes are emerging as a promising product opportunity in the CBD supplement industry, positioning CBDL to capture first-mover advantage and expand market share.